Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease
About this item
Full title
Author / Creator
Ellis, Stephen G , Kereiakes, Dean J , Metzger, D. Christopher , Caputo, Ronald P , Rizik, David G , Teirstein, Paul S , Litt, Marc R , Kini, Annapoorna , Kabour, Ameer , Marx, Steven O , Popma, Jeffrey J , McGreevy, Robert , Zhang, Zhen , Simonton, Charles , Stone, Gregg W and ABSORB III Investigators
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In a randomized trial involving 2008 patients with coronary disease, an everolimus-eluting bioresorbable scaffold was noninferior to an everolimus-eluting cobalt–chromium stent with respect to target-lesion failure at 1 year.
Contemporary drug-eluting coronary stents have been associated with better clinical outcomes than have either bare-metal...
Alternative Titles
Full title
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1733188901
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1733188901
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1509038
